PFSA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PFSA is not a good buy right now for an impatient investor. The stock is trading as a micro-price name (~$0.093 pre-market) below the key pivot (0.105), there are no Intellectia buy signals, no recent news catalysts, and fundamentals show a sharp deterioration (large net loss and deeply negative EPS with zero revenue). I would avoid new entries and would sell/exit rather than buy at this level.
Trend/structure: Price (~0.0929 pre-market) is below the pivot (0.105), meaning the technical setup is still weak until it reclaims that level. Momentum: MACD histogram is above 0 (0.0027) but positively contracting, which suggests bullish momentum is fading rather than strengthening. RSI(6) is 39.93 (neutral-to-weak), not showing a strong oversold bounce signal. Moving averages are converging, indicating indecision and lack of a clean trend. Key levels: Support S1=0.0866 then S2=0.0749; resistance R1=0.124 then R2=0.136. For a buy-now case, you’d want strength back above ~0.105 and ideally through 0.124—currently not in place. Pattern-based outlook provided: next week skew is negative (-4.08%), which aligns with the current weak setup, despite a more optimistic 1-month projection (+12.31%).
No negative news flow in the last week (no fresh headline overhang). Pattern-based projection shows a potential +12.31% over the next month. Nearby technical support at 0.0866 may attract short-term dip buyers if it holds. Hedge fund and insider trading trends are neutral (no recent heavy selling signal from those groups in the provided data).
No Intellectia proprietary buy signals today (AI Stock Picker: no signal; SwingMax: no recent signal), reducing confidence for a near-term trade. Price is below pivot resistance (0.105), so the stock is not in a confirmed uptrend. Momentum is not improving (MACD positive but contracting; RSI below 40). No news catalysts in the past week to drive an event-based move. Congress trading: no recent data available (no supportive signal from political/influential buying).
Latest quarter: 2025/Q3. Revenue was 0 (0.00% YoY), while profitability deteriorated sharply: Net Income fell to -22,192,000 (down -24,439.47% YoY) and EPS dropped to -0.7 (down -3,600.00% YoY). With zero revenue and a much larger loss, the growth/quality trend in the latest quarter is decisively negative.
No analyst rating or price target change data was provided, so there is no observable recent trend in Wall Street upgrades/downgrades. Based strictly on the available dataset, the main 'pro' case would be technical bounce potential from support and the 1-month pattern projection; the main 'con' case is the severe Q3 financial deterioration, lack of catalysts, and lack of confirmed technical uptrend.
